Ribozyme inhibition of alphavirus replication.
A model system to examine the expression and antiviral activity of trans-acting ribozymes in mammalian cells has been developed and evaluated. Hairpin ribozymes were engineered to cleave a specific site, identified by a combinatorial activity-based selection method, within genomic and subgenomic RNA species of Sindbis virus. Transiently transfected cells expressed moderate levels of ribozyme (approximately 50,000 molecules/cell) with predominant nuclear localization and a short half-life (23 min). Stable cell lines expressed ribozymes at modest levels (approximately 2,000 molecules/cell). Ribozyme-mediated RNA cleavage activity was detected in cell extracts. Clonal cell lines were challenged with recombinant Sindbis virus, and viral replication was examined using plaque formation and green fluorescent protein assays. Significant inhibition of viral replication was observed in cells expressing the active antiviral ribozyme, and lower levels of inhibition in control cells expressing inactive or irrelevant ribozymes. These findings are consistent with a model in which inhibition of viral replication occurs via ribozyme cleavage of viral RNAs, suggesting that ribozymes may represent useful antiviral agents.
Seyhan
Attila A
AA
Somagenics, Inc., Santa Cruz, California 95060, USA.
Vitiello
Danielle
D
Shields
Michele T
MT
Burke
John M
JM
D000524:Alphavirus / Q000502:physiology*; D000818:Animals; D002384:Catalysis; D002460:Cell Line; D006224:Cricetinae; D049452:Green Fluorescent Proteins; D008164:Luminescent Proteins; D009690:Nucleic Acid Conformation; D016337:RNA, Catalytic / Q000494:pharmacology*; D014162:Transfection; D014779:Virus Replication / Q000187:drug effects*
D008164:Luminescent Proteins; D016337:RNA, Catalytic; D049452:Green Fluorescent Proteins